Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
November 2014

Adjunctive Atorvastatin (Lipitor) for MDD?
In a study of patients with major depressive disorder (MDD), adding atorvastatin (Lipitor) to citalopram (Celexa and others) treatment was associated with lower scores on the Hamilton Depression Rating Scale (HDRS).

Antidepressants, Pregnancy, and the Risk of Cardiac Defects
A large cohort study found that commonly prescribed antidepressant medications do not appear to carry cardiac teratogenic effects when used during pregnancy.

Psychotropics and Suicide
FDA warnings that antidepressants and atomoxetine (Strattera) could increase suicidal thinking impacted prescribing patterns and the incidence of psychotropic drug poisonings.

In Brief
Exposure to SSRIs Does Not Increase Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Infection; Hyperconnectivity Exists Between Brain Networks in Young Unmedicated Remitted Patients with Depression

Antipsychotic Dose Reduction and Adverse Effects
A study of patients with schizophrenia found that decreasing the dose of risperidone (Risperdal and others) or olanzapine (Zyprexa and others) by half did not affect the rate of adverse metabolic effects.

Affiliated Links

The Journal of Clinical Psychiatry

The University of Arizona Health Sciences Center- Department of Psychiatry

American Academy of Child and Adolescent Psychiatry

American Association of Suicidology

American Psychiatric Association

American Society for Adolescent Psychiatry

American Society of Addiction Medicine

American Society of Clinical Psychopharmacology

Autism Society of America

Depression and Bipolar Support Alliance (DBSA)

National Alliance for Research on Schizophrenia and Depression (NARSAD)

National Alliance for the Mentally Ill

National Association of Alcoholism and Drug Abuse Counselors

National Institute of Mental Health

National Mental Health Association